Intracellular production of hepatitis C E1 and E2 truncated polypeptides
US7429385B2 · kind B2 · utility
3Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2003 |
| Grant date | Sep 30, 2008 |
| Priority date | — |
| Expiry date | Jul 2, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/923
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for obtaining recombinantly produced, C-terminally truncated, E1 and E2 polypeptides from cell lysates are disclosed. The intracellularly expressed truncated molecules display improved biological properties as compared to their secreted counterparts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.